CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
adjuvant chemotherapy regimen in patients with early-stage luminal B breast cancer.The primary endpoint will be to evaluate the fea...
Phase 2
Milan, Italy
Breast cancer is the most common form of cancer among women. For patients candidated for adjuvant chemotherapy and endocri...
Phase 3
milano, Milano, Italy and 74 other locations
adjuvant systemic treatment instead of adjuvant chemotherapy followed by endocrine therapy in older patients with stage II-III ER+/HER2- early breast...
Phase 2
Monza, Italy and 72 other locations
DESTINY-Breast07 will investigate the safety, tolerability, and anti-tumour activity of trastuzumab deruxtecan (T-DXd) in combination with o ...
Phase 1, Phase 2
Milan, Italy and 71 other locations
-positive / HER2-negative breast cancer which has spread beyond the original tumor and/or to other organs.During this study, anti-h...
Phase 3
Milan, Italy and 53 other locations
This program initially aims to recruit 1300 breast cancer patients from a large number of hospitals across Europe. Eligible patient...
Milan, Italy and 52 other locations
with NECTIN4-amplified recurrent, unresectable, or metastatic breast cancer who have received prior therapy (see inclusion criteria...
Phase 2
Milan, Italy and 17 other locations
to anti-HER2-based therapy plus endocrine therapy alone in improving the outcomes of subjects with hormone receptor-positive, HER2+ metastatic breast...
Phase 3
Milan, Italy and 107 other locations
A study to learn about a new medicine called ARV-471 (PF-07850327) in people who have advanced metastatic breast cancer....
Phase 3
Monza, Lombardy, Italy and 319 other locations
(ARV-471/PF-07850327) given together with palbociclib in advanced breast cancer. In particular, the study will compare the combinat...
Phase 3
Monza, Lombardy, Italy and 28 other locations
Clinical trials
Research sites
Resources
Legal